Advertisement
NuAire
NuAire

The Scientist

» clinical trials and developmental biology

Most Recent

image: Fellow Travelers

Fellow Travelers

By | February 1, 2013

Collective cell migration relies on a directional signal that comes from the moving cluster, rather than from external cues.

1 Comment

image: Go Forth, Cells

Go Forth, Cells

By | February 1, 2013

Watch the cell transplant experiments in zebrafish that suggest certain embryonic cells rely on intrinsic directional cues for collective migration.

0 Comments

image: Dung Defeats Drugs

Dung Defeats Drugs

By | January 18, 2013

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Researchers Risk Insider Trading

Researchers Risk Insider Trading

By | January 14, 2013

Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.

0 Comments

image: Failing Alzheimer’s Test?

Failing Alzheimer’s Test?

By | December 19, 2012

Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.

0 Comments

image: Top Science Scandals of 2012

Top Science Scandals of 2012

By | December 17, 2012

This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct

20 Comments

image: 2012 Multimedia Roundup

2012 Multimedia Roundup

By | December 14, 2012

The science images and videos that captured our attention in 2012

1 Comment

image: Chelation Therapy Under Scrutiny

Chelation Therapy Under Scrutiny

By | November 15, 2012

A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.

6 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Bethyl Laboratories
Bethyl Laboratories